UK MP Crispin Blunt raised the question of rescheduling psilocybin in Parliament this week after PM Boris Johnson gave Blunt personal reassurance back in May that...
A philanthropic programme with a focus on the psychedelic sector has been launched to harness the power of innovative mental health approaches for social change.
With limited treatment options available for the condition, one company is setting out to explore the neurogenic potential of psychedelics to combat the cognitive decline of...
Meet Delic, a psychedelic and wellness event and expo for newcomers and veterans in the psychedelics space will take place in AREA15 in Las Vegas, this...
Currently, there is no cure for Parkinson’s Disease, however, certain medications can help improve symtoms.
Real-time quantification of brain activity during the psychedelic experience has been a major barrier within psychedelic research.
Seattle council has unanimously voted to pass a resolution to decriminalise entheogenic substances.
A free, virtual event is to explore the use of psychedelics for alcohol use disorder and binge drinking.
Results from a recent study have demonstrated a significant reduction in depressive symptoms and suicidality using ketamine as a solo treatment.
Data from Lobe Sciences has demonstrated that combination therapy of psilocybin and N-Acetylcysteine is more effective than monotherapy for mTBI and PTSD.
